Special Resource. Drugs to be Used with a Filter for Preparation and/or Administration
|
|
|
- Kenneth Boone
- 9 years ago
- Views:
Transcription
1 Hospital Pharmacy Volume 42, Number 4, pp Wolters Kluwer Health, Inc. Special Resource Drugs to be Used with a Filter for Preparation and/or Administration Prepared by: Wolters Kluwer Health/Facts and Comparisons Date: March 9, 2007 Disclaimer: While every effort has been made to ensure the accuracy and completeness of the information presented in this chart, the reader is advised that the authors or Wolters Kluwer Health cannot be responsible for the currency of the information, for any errors or omissions, or for any consequences that may arise. The reader should consult the product package insert for the most up-to-date information. Abatacept (Orencia) Immunomodulator 0.2 to 1.2 micron Administer with an infusion set and a sterile nonpyrogenic, low-protein-binding filter. Abciximab (ReoPro) Glycoprotein IIb/IIIa 0.2 or 0.22 micron For a bolus injection, filter prior to inhibitor administration; for continuous infusion, filter either upon admixture (using a sterile, nonpyrogenic, low-protein-binding filter) or upon administration (using an inline, sterile, nonpyrogenic, low-protein-binding filter). Agalsidase beta Enzyme 0.2 micron Do not use filter needles during the preparation (Fabrazyme) of the infusion; diluted solution should be filtered through an inline low-protein-binding filter during administration. Alglucosidase alfa Enzyme 0.2 micron Do not use filter needles during the preparation (Myozyme) of the infusion; diluted solution should be filtered through an inline low-protein-binding filter during administration. Alpha-1 Respiratory enzyme See individual proteinase package inserts inhibitor (eg, Prolastin, Aralast, Zemaira) Amiodarone Antiarrhythmic agent Not specified Use a 0.2 micron inline filter during (Cordarone) administration; recommended by manufacturer. Another source suggests no significant loss of drug potency with the use of a 0.22 micron cellulose ester membrane filter. 1,2 Amphotericin B Antifungal agent 1 micron or larger Filter may be used during administration. desoxycholate mean pore (Amphocin, diameter (inline Fungizone) membrane filter) Antihemophilic Antihemophilic agent Not specified Use filtered needle provided by manufacturer. factor (eg, Adurate, Kogenate) Antihemophilic Antihemophilic factor Not specified Use filter for withdrawal from the vial. factor/von combination Willebrand Factor Complex (Humate P) 378 Volume 42, April 2007
2 Antithymocyte Immune globulin 0.22 micron globulin inline filter (Thymoglobulin) Antithrombin III Antithrombin agent Not specified Use filter needle provided by manufacturer. (Thrombate III) Asparaginase Antineoplastic agent 5 micron Filter during intravenous (IV) administration. (Elspar) Botulism immune Immune globulin 18 micron Use inline or syringe-tip sterile, disposable filter. globulin IV (BabyBIG) Busulfan (Busulfex) Antineoplastic agent 5 micron Do not use polycarbonate syringes or polycarbonate filter needles with busulfan; only use the 5 micron nylon 1 filter needle provided; use one filter per ampule. Cetuximab (Erbitux) Monoclonal antibody 0.22 micron inline filter Citric acid, glucono- Urinary irrigant Not specified After thorough mixing, filter the solution delta-lactone, and through a coarse filter. magnesium carbonate (Renacidin) Cladribine (Leustatin) Antineoplastic agent 0.22 micron When preparing the 7-day infusion solution, both cladribine and the diluent should be passed through a sterile disposable hydrophilic syringe filter as each solution is being introduced into the infusion reservoir. Clofarabine (Clolar) Antineoplastic agent 0.2 micron Filter prior to dilution. Cytomegalovirus Immune globulin 15 micron inline A 0.2 micron filter is also acceptable. immune globulin IV, filter human (CytoGam) Digoxin immune Detoxification agent 0.22 micron Fab (Digibind) membrane filter Epoprostenol sodium Vasodilator 0.22 micron An inline filter was used during clinical trials. (Flolan) Ferumoxides Diagnostic agents 5 micron (Feridex IV) Galsulfase Enzyme 0.2 micron Do not use a filter during preparation of the (Naglazyme) solution; administer with a polyvinyl chloride (PVC) infusion set equipped with an inline, lowprotein-binding filter. Gemtuzumab Monoclonal antibody 1.2 micron terminal Can be given through central or peripheral ozogamicin filter line; administer through a separate line (Mylotarg) equipped with a low-protein-binding, 0.2 to 1.2 micron terminal filter; manufacturer states: The following filter membranes are qualified: 0.22 or 1.2 micron polyether sulfone (PES) Supor; 1.2 micron acrylic copolymer hydrophilic filter (Versapor); 0.8 micron cellulose mixed ester (acetate and nitrate) membrane; 0.2 micron cellulose acetate membrane. 1 Hemin (Panhematin) Hemin agent 0.45 micron or smaller terminal filter Hospital Pharmacy 379
3 Hyaluronidase Enzyme 5 micron Use a filter needle when withdrawing the powder for reconstituted solution from the vial. injection (Vitrase) Idursulfase Enzyme 0.2 micron Filter to be used with an infusion set. (Elaprase) Imiglucerase Enzyme 0.2 micron Diluted solution may be filtered through an (Cerezyme) inline, low-protein-binding filter during administration. Immune Immune globulin See individual globulin IV package inserts (eg, Gammagard, Flebogamma) In-111 ibritumomab Radioimmunotherapeutic 0.22 micron A low-protein-binding filter should be inline tiuxetan and Y-90 monoclonal antibody between the syringe and infusion port prior ibritumomab tiuxetan to injection of each component. (Zevalin) Infliximab (Remicade) Monoclonal antibody 1.2 micron or smaller inline filter Inulin Diagnostic agent Not specified Administer through a filter. Itraconazole Antifungal agent Not specified Use infusion set with filter provided by the (Sporanox) manufacturer. Lansoprazole Proton pump inhibitor 1.2 micron Administer using inline filter provided. (Prevacid IV) Laronidase Enzyme 0.2 micron Do not use a filter during preparation of the (Aldurazyme) solution; administer with a PVC infusion set equipped with an inline, low-protein-binding filter. Lymphocyte Immune globulin 0.2 to 1 micron immune globulin, antithymocyte globulin (Atgam) Mafenide Topical burn preparation 0.22 micron Filter reconstituted solution prior to use; topical (Sulfamylon) use only. Mannitol Osmotic diuretic 5 micron inline filter To be used when infusing concentrated mannitol (20% or more). Methacholine Diagnostic agent 0.22 micron A sterile, bacterial-retentive filter should be used (Provocholine) when transferring a solution from each vial (at least 2 ml) to a nebulizer; initial use only. Morphine sulfate Opioid 0.22 micron Prepare soluble tablets in sterile water and filter soluble tablets for prior to administration. injection Morphine sulfate Opioid 5 micron or smaller Filter through a microfilter before injecting for intrathecal into the microinfusion device; intrathecal use administration only. (Infumorph) Muromonab-CD3 Monoclonal antibody 0.2 or 0.22 micron Draw solution into a syringe through a low- (Orthoclone OKT3) protein-binding filter. Paclitaxel (Taxol, Antineoplastic agent 0.22 micron or Administer through an inline filter; use of a Onxol) smaller filter is not recommended for Abraxane. Panitumumab Monoclonal antibody 0.2 or 0.22 micron Administer by an IV infusion pump using a (Vectibix) low-protein-binding inline filter. 380 Volume 42, April 2007
4 Pentetate calcium Detoxification agent Not specified May be filtered using a sterile filter if particles trisodium are seen subsequent to opening of the ampule. Phenytoin Anticonvulsant Not specified Although not recommended, some studies sodium, (inline filter) ndicate that an IV infusion of phenytoin may parenteral be feasible if proper precautions are observed, such as a suitable vehicle (eg, 0.9% sodium chloride or Ringer s lactated injection), appropriate concentration, preparing the infusion shortly before administration, and using an inline filter; according to most studies, a 0.22 micron inline filter is required 1,3 ; phenytoin sodium (250 mg/5ml in a 5 ml syringe) was filtered at a rate of 1 ml/min through a 5 micron stainless steel depth filter without significant reduction in potency. 2 Ranibizumab Vascular endothelial 5 micron Withdraw the solution from the vial through a (Lucentis) growth factor 5-micron, 19-gauge filter needle attached to a antagonist 1 ml tuberculin syringe; for intravitreal injection only. Respiratory Immune globulin Larger than An inline filter may be used for RSV-IGIV syncytial virus 15 micron infusions. immune globulin, IV (RSV-IVIG) (RespiGam) Streptokinase Thrombolytic enzyme 0.8 micron or larger (Streptase) Thiotepa Antineoplastic agent 0.22 micron Filter prior to administration; polysulfone (Thioplex) membrane (Gelman s Sterile Acrodisc, Single Use) or triton-free mixed ester of cellulose/pvc (Millipore s MILLEX-GS Filter Unit) are recommended by the manufacturer. Tositumomab Radioimmunotherapeutic 0.22 micron Administer via IV tubing set with an inline filter. and iodine 131 monoclonal antibody The same IV tubing set and filter must be used I-tositumomab throughout the entire dosimetric or therapeutic (Bexxar) step; a change in filter can result in loss of drug. Vaccinia immune Immune globulin 0.22 micron Administer VIGIV via an IV catheter with an globulin IV (VIGIV) administration set that contains an inline filter. Verteporfin Ophthalmic 1.2 micron Administer using a syringe pump and inline (Visudyne) phototherapy agent filter; use of an inline filter (pore size 0.22 to 1.2 microns) is required for administration. 1 a Note: For consistency, the term micron is used to encompass all terms meaning the same (eg, micrometer, mcm, mm) References 1. Gahart BL, Nazareno AR. Intravenous Medications: A Handbook for Nurses and Health Professionals. 23rd ed. St. Louis, MO: Mosby Elsevier; Trissel LA. Handbook on Injectable Drugs. 4th ed. Bethesda, Maryland: American Society of Health-System Pharmacists; Drug Facts and Comparisons. Drug Facts and Comparisons 4.0 [online] Available from Wolters Kluwer Health, Inc. Accessed March 9, Volume 42, April 2007
5 INDEX TO ADVERTISERS American Health Packaging Pravastatin Hospira Hospira Hospira Worldwide Magnesium Sulfate Janssen Pharmaceutical Invega a 290, 368a 370 King Pharmaceuticals Thrombin JMI KV Pharmaceuticals InveAmp Medi-Dose, Inc. Unit Dose Packaging Ortho Biotech Procrit Cover 4 Pfizer, Inc. Geodon IM Schering Plough Noxafil , TEVA Pharmaceuticals USA Azithromycin Wyeth Pharmaceuticals Tygacil Cover 2, Volume 42, April 2007
Filtration Guidelines for the Administration of Intravenous Medications UK Pharmacy Services Revised 8/2010
iltration Guidelines for the Administration of Intravenous Medications UK Pharmacy Services Revised 8/2010 SUMMARY O CHANGES: Green = Added from literature (Lexi-Comp, Micromedex, pkg inserts) Yellow =
Monoclonal antibody (mab) products are currently a fast
Antibody Monoclonal Therapeutics Janice M. Reichert, Ph.D. Monoclonal antibody (mab) products are currently a fast growing category of drugs. Like antibodies produced naturally by the human immune system,
Reconstitution of Solutions
Chapter 12 Reconstitution of Solutions Reconstitution Process of mixing and diluting solutions Some medications supplied in powder form and must be mixed with liquid before administration Parts of Solutions
National Patient Safety Agency. Risk Assessment of Injectable Medicines. STEP 1 Local Risk Factor Assessment. STEP 2 Product Risk Factor Assessment
NPSA Injectable Medicines Risk Assessment Tool National Patient Safety Agency Risk Assessment of Injectable Medicines STEP 1 Local Risk Factor Assessment. Carry out a baseline assessment in a near patient
RECONSTITUTING MEDICATIONS: HOW TO FLUFF UP MEDICATIONS
RECONSTITUTING MEDICATIONS: HOW TO FLUFF UP MEDICATIONS After the completion of this module you will be able to: Define medication reconstitution. Read a medication label. Reconstitute a medication. Calculate
Use of the Injectable Medicines Guide website in clinical areas - IntraVENOUS medicine monographs (January 2013)
Use of the Injectable Medicines Guide website in clinical areas - IntraVENOUS medicine monographs (January 2013) Introduction The IntraVENOUS medicines section of the Injectable Medicines Guide website
Gloucestershire Hospitals
Gloucestershire Hospitals NHS Foundation Trust TRUST GUIDELINE INFLIXIMAB PRESCRIBING AND ADMINISTRATION 1. INTRODUCTION Infliximab is an anti-tumour necrosis factor-α (Anti-TNF) antibody. It is from a
MEDICAL CENTER ADMINISTRATIVE POLICY AND PROCEDURES SCOPE KFH Hospital, City Section No.
of 22 I. Purpose To establish safe medication practices for High Alert medications to maximize the safety of the medication processes associated with these medications. II. Policy. High alert medications
BAPTIST HEALTH MEDICATION EXAMINATION INFORMATION SHEET
BAPTIST HEALTH MEDICATION EXAMINATION INFORMATION SHEET Before you begin employment in the role of RN or LPN, you are required to take a Medication Administration Exam. The exam may be administered at
ADMINISTRATION OF INTRAVENOUS PUSH/DIRECT MEDICATIONS
SASKATOON DISTRICT HEALTH Department of Nursing Affairs ADMINISTRATION OF INTRAVENOUS PUSH/DIRECT MEDICATIONS SPECIAL NURSING PROCEDURE LEARNING PACKAGE This package provides the basic information necessary
Hydration, IV Infusions, Injections and Vaccine Charge Process
There are a number of items to be considered when billing for the Nursing service to perform drug therapy, the charge process is divided into three specific groups of codes and processes. 1. Hydration
Documentation Summary for Chemotherapy Administration, Nonchemotherapy Injections and Infusions
Documentation Summary for Chemotherapy Administration, Nonchemotherapy Injections and Infusions Documentation to Support Medical Necessity of Chemotherapy Services Date: April 23, 2012 Source Information:
PREPARATIONS: Adrenaline 1mg in 1ml (1:1000) Adrenaline 100micrograms in 1ml (1:10,000)
ADRENALINE Acute hypotension Via a CENTRAL venous line Initially 100-300 nanograms/kg/minute 0.1-0.3 microgram/kg/minute adjusted according to response up to a maximum of 1.5 micrograms/kg/minute. Increase
Understanding ph and Osmolarity. Marc Stranz, PharmD
Understanding ph and Osmolarity Marc Stranz, PharmD Outline ph and osmolarity tolerance guidelines, Definitions of ph and osmolarity, ph and osmolarity in vitro data, ph and osmolarity of common infusions,
Ward 29 guide to the safe preparation and administration of intravenous (IV) antibiotics at home
Ward 29 guide to the safe preparation and administration of intravenous (IV) antibiotics at home Contents Page Important contact numbers 1 General information on preparing and administering IV antibiotics
Good practice for the preparation of injectable medicines in clinical areas
Further reading Dougherty L and Lister S (Eds). The Royal Marsden Hospital Manual of Clinical Nursing Procedures (th edition), Blackwell Publishing, Oxford, 00. NMC standards for medicines management (008).
Products for the Treatment of Factor VIII Deficiency
Products for the Treatment of Factor VIII Deficiency Conference Call August 24, 2004 7pm-8pm Presenters: Marcus E. Carr, MD, PhD & Gita V. Massey, MD I. Overview of Factor VIII products currently on the
Date effective: Jan 2005 Date revised: June 2015
Section H: Administration of Blood Products Page 1 of 8 I. Introduction... 1 II. Intravenous (IV) Access... 2 Peripheral Line:...2 Central Venous Catheter:...2 III. Compatible Solutions with Blood Products...
NOTICES DEPARTMENT OF HEALTH
NOTICES DEPARTMENT OF HEALTH Approved Drugs for ALS Ambulance Services [43 Pa.B. 3060] [Saturday, June 1, 2013] Under 28 Pa. Code 1005.11 (relating to drug use, control and security), the following drugs
INTRAVENOUS DRUG QUICKGUIDE
INTRAVENOUS DRUG QUICKGUIDE GENERAL NOTES IMPORTANT THIS GUIDE IS AN AIDE MEMOIRE ONLY, AND SHOULD NOT REPLACE YOUR PROFESSIONAL REQUIREMENT TO USE MANUFACTUER S LICENSED INFORMATION TO INFORM YOUR PREPARATION
Medications or therapeutic solutions may be injected directly into the bloodstream
Intravenous Therapy Medications or therapeutic solutions may be injected directly into the bloodstream for immediate circulation and use by the body. State practice acts designate which health care professionals
NDC HCPCS HCPCS Description NDC Description Effective Date End Date X-Over Only
Updated 5.5.14 NDC HCPCS HCPCS Description NDC Description Effective Date End Date X-Over Only 68152-0103-03 A9543 YTTRIUM Y-90 IBRITUMOMAB TIUXETAN ZEVALIN Y-90 VIAL 9/1/2013 12/31/2013 50419-0320-05
Syringe. Product Usage Information: Precautions:
Syringe Standard Draw Procedure In-Patient, Automated Retraction Non-Reusable. Prepare and give injection using aseptic technique according to institutional policy.. For injection into patients, continue
Classification of Hazardous Drugs by NIOSH
Classification of Hazardous Drugs by NIOSH Thomas H. Connor, PhD Research Biologist National Institute for Occupational Safety and Health NIOSH Goals Protect workers from exposure to hazardous drugs Provide
MEDICATION MANUAL Policy & Procedure
MEDICATION MANUAL Policy & Procedure TITLE: High Alert Medication NUMBER: MM 50-010 Effective Date: September 13, 2013 Page 1 of 6 Applies To: Holders of Medication Manual This policy is applicable to
Chemotherapy Administration, Hydration and Therapeutic, Prophylactic, and Diagnostic Injections and Infusions
Chemotherapy Administration, Hydration and Therapeutic, Prophylactic, and Diagnostic Injections and Infusions Table of Contents: Overview... Professional Services... 2 Services... 4 Overview Chemotherapy
DRUG CALCULATIONS. Mathematical accuracy is a matter of life and death. [Keighley 1984]
DRUG CALCULATIONS Mathematical accuracy is a matter of life and death. [Keighley 1984] At the end of this practice sheet, you will be able to: Perform simple arithmetical tasks. Accurately calculate drug
MMA - 2005 Drug Administration Coding Revisions
Related Change Request (CR) #: 3631 Related CR Release Date: December 10, 2004 Related CR Transmittal #: 129 Effective Date: January 1, 2005 Implementation Date: January 17, 2005 MMA - 2005 Drug Administration
An introduction to High Risk Medications
An introduction to High Risk Medications Une politique sure des médicaments : déjà deux approches 25 octobre 2013 Danguy Christine Hôpital A. Vésale An introduction to High Risk Medications 1. High Risk
Promoting safer use of injectable medicines
Promoting safer use of injectable medicines A template standard operating procedure for: prescribing, preparing and administering injectable medicines in clinical areas Introduction The use of injectable
COMPOUNDING PHARMACY IN THE HOSPITAL SETTING SATURDAY/11:30AM-12:30PM
HOSPITAL FOCUS: COMPOUNDING PHARMACY IN THE HOSPITAL SETTING SATURDAY/11:30AM-12:30PM ACPE UAN: 0107-9999-16-034-L04-T 0.1 CEU/1 hr Activity Type: Knowledge-Based Learning Objectives for Pharmacy Technicians:
Policies & Procedures. ID Number: 1118
Policies & Procedures Title: INTRAVENOUS AND/OR PERIPHERAL SALINE LOCK INSERTION AND MAINTENANCE ID Number: 1118 Authorization [X] SHR Nursing Practice Committee Source: Nursing Date Revised: September
By Lawrence A. Trissel, B.S., R.Ph., FASHP. Modified from the original presentation March 9, 2006
USP Chapter : Beyond Use Dating, Stability, and Storage Modified from the original presentation March 9, 2006 By Lawrence A. Trissel, B.S., R.Ph., FASHP Supported by an unrestricted educational grant
It has been recommended that all
Papers For personal use only. Not to be reproduced without permission of the editor ([email protected]) Development and application of a risk assessment tool to improve the safety of patients receiving
The Future of Monoclonal Antibodies Therapeutics: Innovation in Antibody Engineering, Key Growth Strategies and Forecasts to 2011
Brochure More information from http://www.researchandmarkets.com/reports/344881/ The Future of Monoclonal Antibodies Therapeutics: Innovation in Antibody Engineering, Key Growth Strategies and Forecasts
Recommendations for the Safe Use of Handling of Cytotoxic Drugs
Recommendations for the Safe Use of Handling of Cytotoxic Drugs Introduction Cytotoxic drugs are toxic compounds and are known to have carcinogenic, mutagenic and/or teratogenic potential. With direct
PHARMACY TECHNICIAN COURSE DESCRIPTIONS
PHARMACY TECHNICIAN COURSE DESCRIPTIONS OCCUPATIONAL COMPLETION POINTS AND PROGRAM LENGTH: * Basic Healthcare Worker OCP A 90 Hours (COURSE #HSC 0003) * Community Pharmacy Technician OCP B 360 Hours (COURSE
EDUCATOR S LESSON PLAN
EDUCATOR S LESSON PLAN Pharmacy Technician Training Program Student Version Orientation Orientation introduces the student to basic terms and definitions. An introduction to the Pharmacy Technician Certification
Dilution and. Concentration. Chapter 10 TERMS OBJECTIVES % C 4 5 6 X
Chapter 10 Dilution and TERMS % C 7 8 9. 4 5 6 X Alligation Alligation alternate Alligation medial Diluent Stock solution Concentration OBJECTIVES Upon completion of this chapter, the technician student
LESSON ASSIGNMENT. After completing this lesson, you should be able to: 2-1. Compute medication dosages by the ratio and proportion method.
LESSON ASSIGNMENT LESSON 2 Pharmacology TEXT ASSIGNMENT Paragraphs 2-1 through 2-34. LESSON OBJECTIVES After completing this lesson, you should be able to: 2-1. Compute medication dosages by the ratio
Alert. Patient safety alert. Promoting safer use of injectable medicines. 28 March 2007. Action for the NHS and the independent sector
Patient safety alert 20 The National Patient Safety Agency (NPSA) received around 800 reports a month to its National Reporting and Learning System (NRLS) relating to injectable medicines between January
MISSISSIPPI BOARD OF NURSING IV THERAPY COURSE FOR THE EXPANDED ROLE LICENSED PRACTICAL NURSE COURSE OUTLINE
THEORY MINIMUM 40 HOURS COURSE OUTLINE UNIT TOPIC HOURS* I LEGAL ASPECTS AND PRACTICE OF IV THERAPY 1 II REVIEW OF ANATOMY AND PHYSIOLOGY 6 III FLUID AND ELECTROLYTE BALANCE 10 IV EQUIPMENT AND PROCEDURES
Illinois Valley Community College Nursing Program Math Questions
Illinois Valley Community College Nursing Program Math Questions 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. How many mg of the antibiotic Penicillin would you prepare for a child who weighs
Illinois Department of Revenue Regulations TITLE 86: REVENUE CHAPTER I: DEPARTMENT OF REVENUE
Illinois Department of Revenue Regulations Title 86 Part 530 Section 530.110 Covered Prescription Drugs TITLE 86: REVENUE CHAPTER I: DEPARTMENT OF REVENUE PART 530 SENIOR CITIZENS AND DISABLED PERSONS
Correct Coding for Infusions and Injections. Agenda. Supervision Levels. Regan Tyler, CPC, CPC-H, CPMA, CEMC, ACS-EM
Correct Coding for Infusions and Injections Regan Tyler, CPC, CPC-H, CPMA, CEMC, ACS-EM 1 Agenda The hierarchy facility vs. clinic for infusion coding - Initial, each additional, each sequential, concurrent
Policy and Procedure Flushing and / or Blood withdrawal Aspiration Procedure For PICC Line and Midline Catheters
Policy and Procedure Flushing and / or Blood withdrawal Aspiration Procedure For PICC Line and Midline Catheters Purpose: Blood Withdrawal: To obtain blood samples for laboratory evaluation, eliminating
Pediatric Dosages CHAPTER 18 ALERT LEARNING OBJECTIVES
CHAPTER 18 Pediatric Dosages LEARNING OBJECTIVES On completion of the materials provided in this chapter, you will be able to perform computations accurately by mastering the following mathematical concepts:
Administration of Medications & Fluids via a Peripheral Intravenous Cannula
Administration of Medications & Fluids via a Peripheral Intravenous Cannula Clinical S.O.P. No.: 22.0 Compiled by: Approved by: Review date: November 2016 Administration of Medications & Fluids via S.O.P.
A4.7 Management of a totally occluded central catheter and persistent withdrawal occlusion (PWO)
A4.7 Management of a totally occluded central catheter and persistent withdrawal occlusion (PWO) Types of Catheter Related Thrombotic A catheter-related thrombus may be intraluminal (inside the catheter)
Helping to protect you from exposure to hazardous drugs
Helping to protect you from exposure to hazardous drugs Closed system solution: Texium closed male luer and SmartSite needle-free valve products What you can t see can hurt you The risks are well documented
GUIDELINES FOR NUCLEAR PHARMACY TECHNICIAN TRAINING PROGRAMS
GUIDELINES FOR NUCLEAR PHARMACY TECHNICIAN TRAINING PROGRAMS Prepared by Ad Hoc Committee on Nuclear Pharmacy Technicians Nuclear Pharmacy Section Academy of Pharmacy Practice and Management American Pharmaceutical
HOWS AND WHYS OF CRI ANALGESIA IN SMALL ANIMALS Luisito S. Pablo, DVM, MS, Diplomate ACVA University of Florida, Gainesville, Florida
HOWS AND WHYS OF CRI ANALGESIA IN SMALL ANIMALS Luisito S. Pablo, DVM, MS, Diplomate ACVA University of Florida, Gainesville, Florida Management of severe pain in small animals continues to be a challenge
3% Sodium Chloride Injection, USP 5% Sodium Chloride Injection, USP
PRESCRIBING INFORMATION 3% Sodium Chloride Injection, USP 5% Sodium Chloride Injection, USP IV Fluid and Electrolyte Replenisher Baxter Corporation Mississauga, Ontario L5N 0C2 Canada Date of Revision:
Basic Medication Administration Exam RN (BMAE-RN) Study Guide
Basic Medication Administration Exam RN (BMAE-RN) Study Guide Review correct procedure and precautions for the following routes of administration: Ear drops Enteral feeding tube Eye drops IM, subcut injections
GUIDELINE FOR ADMINISTRATION OF FENTANYL FOR PAIN RELIEF IN LABOUR
GUIDELINE FOR ADMINISTRATION OF FENTANYL FOR PAIN RELIEF IN LABOUR INTRODUCTION Intravenous (IV) Fentanyl is a good option for pain management during labour and should be administered in a safe and competent
02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION REGULATIONS RELATING TO ADMINISTRATION OF INTRAVENOUS THERAPY BY LICENSED NURSES
02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION 380 BOARD OF NURSING Chapter 10: REGULATIONS RELATING TO ADMINISTRATION OF INTRAVENOUS THERAPY BY LICENSED NURSES SUMMARY: This chapter identifies
Chapter 1: Ohio Nursing Laws and Rules Defining Scopes of Practice
Chapter 1: Ohio Nursing Laws and Rules Defining Scopes of Practice 1.0 Contact Hour, Category A This CE activity, OLN-I-1642-15, being offered by Elite CME, Inc. has been approved for 1.0 contact hour,
SECTION OF EMERGENCY MEDICAL SERVICES MINIMUM REQUIRED EQUIPMENT LIST PARAMEDIC
MINIMUM REQUIRED EQUIPMENT LIST PARAMEDIC Trauma Dressing (2) Isolation Kits (2) OB Kit (1) - must contain Bulb syringe Betadine Solution (1 Bottle) Hemostat Window Punch Scalpel Exam Gloves (1 Box) Sterile
Sterilization methods and equipment Lab 1-2
Sterilization methods and equipment Lab 1-2 PHT 434 Sterilization Sterilization a process that by which all viable M.O are removed or destroyed, based on a probability function. Sterilization concept Sterilization
Paramedic Pediatric Medical Math Test
Paramedic Pediatric Medical Math Test Name: Date: Problem 1 Your 4 year old pediatric patient weighs 40 pounds. She is febrile. You need to administer acetaminophen (Tylenol) 15mg/kg. How many mg will
Auvi-Q (epinephrine injection) 0.15mg and 0.3mg (Sanofi)
Auvi-Q (epinephrine injection) 0.15mg and 0.3mg (Sanofi) On Oct. 28, 2015, Sanofi recalled all lots (numbered between 2299596 and 3037230; expiring between March 2016 and December 2016) of both strengths
PROFESSIONAL BOARD FOR EMERGENCY CARE
PROFESSIONAL BOARD FOR EMERGENCY CARE IMPORTANT NOTICE TO ALL EMERGENCY CARE PRACTITIONERS INTRODUCTION OF NEW SCOPE OF PRACTICE FOR REGISTERED EMERGENCY CARE PRACTITIONERS NOVEMBER 2009 Herewith the July
Order Phenytoin dilantin ivpb rate when to order phenytoin level dilantin 30 mg
Order Phenytoin 1 dilantin loading dose iv 2 can you buy dilantin 3 generic phenytoin manufacturers 4 what is a high dilantin level 5 buy generic dilantin 6 dilantin ivpb administration 7 purchase phenytoin
Bishop State Community College. Dosage Calculation Review Study Booklet
Bishop State Community College Dosage Calculation Review Study Booklet Table of Contents Page Numbers Conversion Table. 2 Conversions Facts. 3, 4 Conversion Practice Problems 5 Oral and Parenteral Calculations..
Basic Medication Administration Exam LPN/LVN (BMAE-LPN/LVN) Study Guide
Basic Medication Administration Exam LPN/LVN (BMAE-LPN/LVN) Study Guide Review correct procedure and precautions for the following routes of administration: Ear drops Enteral feeding tube Eye drops IM,
A. ADMINISTERING SUBCUTANEOUS MEDICATIONS INTERMITTENTLY/CONTINUOUSLY B. (SUBCUTANEOUS INFUSION) HYDRODERMOCLYSIS
SUBCUTANEOUS THERAPY A. ADMINISTERING SUBCUTANEOUS MEDICATIONS INTERMITTENTLY/CONTINUOUSLY B. (SUBCUTANEOUS INFUSION) HYDRODERMOCLYSIS PARTS I. Purposes II. General Information III. Responsibilities IV.
NOTICES. Approved and Required Medications Lists for Emergency Medical Services Agencies and Emergency Medical Services Providers
NOTICES Approved and Required Medications Lists for Emergency Medical Services Agencies and Emergency Medical Services Providers [45 Pa.B. 5451] [Saturday, August 29, 2015] Under 28 Pa. Code 1027.3(c)
Monoclonal Antibodies
CORAM S VOLUME 6 Monoclonal Antibodies Monoclonal antibodies are increasingly relied upon as a treatment option for numerous disease states. The goals of this self-study module are to help you understand
Non-Oral Routes of Drug Administration
Non-Oral Routes of Drug Administration Reading: Ansel 9 th edition, p. 161-170 Routes of Drug Administration Over the next series of lectures, we will talk about the biopharmaceutics of several non-oral
Parenteral Administration
Chapter 10 and 11 Parenteral Administration Equipment Syringes Syringe consists of a barrel, a plunger, and a tip. Outside of the barrel is calibrated in milliliters, minims, insulin units, and heparin
NURSING PRACTICE & SKILL
NURSING PRACTICE & SKILL ICD-9 99.29 Author Carita Caple, RN, BSN, MSHS Reviewers Eliza Schub, RN, BSN Sara Richards, MSN, RN Nursing Practice Council Glendale Adventist Medical Center, Glendale, CA Editor
YAKUGAKU ZASSHI 126(4) 289 295 (2006) 2006 The Pharmaceutical Society of Japan
YAKUGAKU ZASSHI 126(4) 289 295 (2006) 2006 The Pharmaceutical Society of Japan 289 Notes Usefulness of the Final Filter of the IV Infusion Set in Intravenous Administration of Drugs Contamination of Injection
A COLLABORATIVE PRACTICE AGREEMENT FOR OPIOID OVERDOSE PREVENTION AND RESPONSE NALOXONE OVERDOSE KIT DISTRIBUTION PROTOCOL
A COLLABORATIVE PRACTICE AGREEMENT FOR OPIOID OVERDOSE PREVENTION AND RESPONSE NALOXONE OVERDOSE KIT DISTRIBUTION PROTOCOL Purpose: To reduce morbidity and mortality from opioid overdose. Policy: Under
PHARMACY TECHNICIAN SERIES
PHARMACY TECHNICIAN SERIES Occ. Work Prob. Effective Last Code No. Class Title Area Area Period Date Action 4058 Pharmacy Technician I 12 446 6 mo. 02/15/04 Revised 4059 Pharmacy Technician II 12 446 6
Indication: Posology: Indication: Posology:
Maklumat tambahan indikasi untuk upload pada laman web Year 2014 Products Approved For Additional Indication (DCA 275 9 Mei 2014) NO PRODUCT (ACTIVE INGREDIENT) 1. 1.1 Trajenta Duo 2.5mg/500mg Film-Coated
Medication Calculation Practice Problems
1 Medication Calculation Practice Problems Dosage Calculation 1. The order is for 60 mg of furosemide (Lasix) po daily. Available to the nurse is Lasix 40 mg/tablet. The nurse would administer how many
CUESTA COLLEGE REGISTERED NURSING PROGRAM CRITICAL ELEMENTS
CUESTA COLLEGE REGISTERED NURSING PROGRAM CRITICAL ELEMENTS LEVELS I through IV A. OVERRIDING CRITICAL ELEMENTS Violation of an overriding area will result in termination and failure of the particular
Aerospace Medical Association
Paulo M. Alves, MD Anthony D. Evans, MBChB Frank S. Pettyjohn, MD Claude Thibeault, MD Aerospace Medical Association Medical Guidelines for Airline Travel In-flight Medical Care Reviewed and accepted by
Bayer HealthCare, LLC Sharps Disposal Submission to CalRecycle July 1, 2014
Bayer HealthCare, LLC Sharps Disposal Submission to CalRecycle July 1, 2014 1. A pharmaceutical manufacturer that sells or distributes a medication in California that is usually intended to be self-injected
POSSIBLE NURSING DIAGNOSIS: Pain Potential for Infection / Infection Fluid volume deficit
1 Procedure for Subcutaneous Over-the-needle Cannula Insertion, Removal, Medication Administration, and Fluid Administration for the Individual in the Home PURPOSE: To provide medication via the subcutaneous
LOS ANGELES COUNTY EMERGENCY MEDICAL SERVICES LOS ANGELES COUNTY EMT-I EXPANDED SCOPE OF PRACTICE
LOS ANGELES COUNTY EMERGENCY MEDICAL SERVICES LOS ANGELES COUNTY EMT-I EXPANDED SCOPE OF PRACTICE Upon completion of this unit of instruction, the student will be able to: LEARNING OBJECTIVES LESSON CONTENT
Coverage and Pricing. of Drugs That Can Be Covered Under. Part B and Part D
Coverage and Pricing Elizabeth Hargrave NORC at the University of Chicago Jack Hoadley of Drugs That Can Be Covered Under Part B and Part D Jennifer Thompson Georgetown University MedPAC A study conducted
PACKAGE LEAFLET: INFORMATION FOR THE USER. PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion. Paracetamol
PACKAGE LEAFLET: INFORMATION FOR THE USER PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion Paracetamol Read all of this leaflet carefully before you start using this medicine. Keep this leaflet.
Needlestick Injury Prevention Assessment Tool
Needlestick Injury Prevention Assessment Tool WHO PROJECT TO PREVENT NEEDLESTICK INJURY and HIV TRANSMISSION AMONG HEALTHCARE WORKERS March 2005 Combined tool for assessing the safety of injections, suturing,
Pharmacy Technician Web Based Calculations Review
Pharmacy Technician Web Based Calculations Review MODULE 3 3 2009 PRESENTED BY: Jenifer Maki, JENIFER PharmD MAKI, PHARMD BRETT SALEM, PHARMD WITH CONTRIBUTIONS DEREK LOMAS, FROM: PHARMD Brett Salem, PharmD
for Extended Stability Parenteral Drugs Third Edition Caryn M. Bing, R.Ph., M.S., FASHP Editor
Extended Stability for Parenteral Drugs Third Edition Editor Caryn M. Bing, R.Ph., M.S., FASHP 1 American Society of Health-System Pharmacists Bethesda, Maryland Contents Preface Acknowledgments x/ Dedication
Administering Medications
Administering Medications Pharmacology for Healthcare Professionals seventh edition Donna F. Gauwitz, R.N., Nursing Consultant Senior Teaching Specialist of Nursing University of Minnesota Minnesota and
Safe Medication Administration Preparation Guide C.O.R.E Essentials
Safe Medication Administration Preparation Guide C.O.R.E Essentials As a new IU Health employee, a portion of your orientation will focus on Safe Medication Administration practices. You will participate
0.9% Sodium Chloride Injection, USP In VIAFLEX Plastic Container
Page 1 of 8 PRESCRIBING INFORMATION 0.9% Sodium Chloride Injection, USP In VIAFLEX Plastic Container IV Fluid and Electrolyte Replenisher Baxter Corporation Mississauga, Ontario L5N 0C2 Canada Date of
Beaumont Hospital Department of Nephrology and Renal Nursing. Guideline for administering Ferinject
Beaumont Hospital Department of Nephrology and Renal Nursing Guideline Name: Guideline for administering Ferinject Guideline Number: 18 Guideline Version: a Developed By: Louise Kelly CNM 1 Renal Day Care
Read the following information carefully before attempting the examples and exercises. TABLETS Formula method. = No. of tablets to be given
drug calculations Read the following information carefully before attempting the examples and exercises. TABLETS Required dose No. of tablets to be given Required dose : Required tablet : Stock tablet
ANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY. Guidelines for Use of Intravenous Isoproterenol
ANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY Guidelines for Use of Intravenous Isoproterenol Major Indications Status Asthmaticus As a last resort for
Good practice for drug calculations
Good practice for drug calculations A step-by-step guide for nurses, doctors and all other healthcare professionals Pharmacyservices 7048 Drug Cal Guide A6 Update_AW.indd 1 22/07/2014 09:55 2 Contents
Calcium Folinate Ebewe Data Sheet
NAME OF THE MEDICINE Calcium folinate injection Composition Active: Calcium folinate (equivalent to 10 mg folinic acid per ml) Inactive: Sodium chloride (7.7mg/mL), qs Water for Injections. Preservative
ONCE ONLY GLUCAGON and Fast Acting Glucose gel (PGD) For nurse administration under Patient Group Direction (Trust wide PGD in place)
ADULT INSULIN PRERIPTION AND BLOOD GLUCOSE MONITORING CHART Ward CONSULTANT DATE OF ADMISSION Please affix Patient s label here Ward Ward.../...year PATIENT NAME....... DATE OF BIRTH... NHS NUMBER.......
Effective: July 28, 2015. Arizona Prior Authorization Requirements Health Net Access, Inc.
Effective: July 28, 2015 Arizona Prior Authorization Requirements Health Net Access, Inc. The following services, procedures and equipment are subject to prior authorization requirements (unless noted
Using a filter should not be difficult either.
Filter Selection and Use Guide Innovative Products for Filtration Choosing a filter doesn t have to be complicated. has simplified the process. Just follow these four easy steps: Step 1: Match your application
